HomepageMedicinePharma Pulse 11/21/24: A Global Standard for Data Sources, 75% of Adults are Obese & more Medicine Pharma Pulse 11/21/24: A Global Standard for Data Sources, 75% of Adults are Obese & more admin Posted on November 25, 2024 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostIndia’s 26 major listed realty firms sell ₹35,000 crore worth properties in Q2; Godrej Properties at top Next PostReading, With Extra Cheese: Remembering Pizza Hut’s ‘Book It!’ You Might Also Like Medicine ADRIATIC Trial Demonstrates Significant Survival Benefit in LS-SCLC, Potentially Shaping Future Treatment Standards admin January 30, 2025 Medicine FDA Approves Arcutis Biotherapeutics’ Zoryve to Treat Patients with Mild to Moderate Atopic Dermatitis admin July 10, 2024 Medicine FDA Approves New Drug Application for Shorla Oncology’s Tepylute, a Ready-to-Dilute Formulation for the Treatment of Breast and Ovarian Cancer admin July 2, 2024 Medicine Novartis' Lutathera Shows Significant Survival Benefit as First-Line Treatment for GEP-NETs admin January 21, 2024
Medicine ADRIATIC Trial Demonstrates Significant Survival Benefit in LS-SCLC, Potentially Shaping Future Treatment Standards admin January 30, 2025
Medicine FDA Approves Arcutis Biotherapeutics’ Zoryve to Treat Patients with Mild to Moderate Atopic Dermatitis admin July 10, 2024
Medicine FDA Approves New Drug Application for Shorla Oncology’s Tepylute, a Ready-to-Dilute Formulation for the Treatment of Breast and Ovarian Cancer admin July 2, 2024
Medicine Novartis' Lutathera Shows Significant Survival Benefit as First-Line Treatment for GEP-NETs admin January 21, 2024